Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
School-based Influenza Vaccination for Control of Epidemic Influenza
NCT00138294Phase 4Completed
- Sponsor
- Baylor College of Medicine
- Start
- Oct 1998
- Primary completion
- Jun 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of live attenuated influenza vaccine in influenza (2 arms), sponsored by Baylor College of Medicine. Primary endpoint: Medically Attended Acute Respiratory Illness Rate at 32 weeks. Started Oct 1998; status: completed.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00138294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00138294.